BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1548519)

  • 41. Phase II trial of etoposide, doxorubicin, and cisplatin combination in advanced measurable gastric cancer. An Eastern Cooperative Oncology Group study.
    Clark JL; Küçük O; Neuberg DS; Benson AB; Taylor SG; Pandya KJ; Mansour EG; Douglass HO; Haller DG
    Am J Clin Oncol; 1995 Aug; 18(4):318-24. PubMed ID: 7625373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial.
    Hartgrink HH; van de Velde CJ; Putter H; Songun I; Tesselaar ME; Kranenbarg EK; de Vries JE; Wils JA; van der Bijl J; van Krieken JH;
    Eur J Surg Oncol; 2004 Aug; 30(6):643-9. PubMed ID: 15256239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase II study of sequential high-dose methotrexate (MTX) and 5-fluorouracil (F) alternated with epirubicin (E) and cisplatin (P) [FEMTX-P] in advanced gastric cancer.
    Roelofs EJ; Wagener DJ; Conroy T; Wils J; Burghouts JT; Fickers M; de Graeff A; Lalisang F; Paillot B
    Ann Oncol; 1993 May; 4(5):426-8. PubMed ID: 8353077
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer.
    Murad AM; Santiago FF; Petroianu A; Rocha PR; Rodrigues MA; Rausch M
    Cancer; 1993 Jul; 72(1):37-41. PubMed ID: 8508427
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study.
    Bajetta E; Di Bartolomeo M; Carnaghi C; Buzzoni R; Mariani L; Gebbia V; Comella G; Pinotti G; Ianniello G; Schieppati G; Bochicchio AM; Maiorino L
    Br J Cancer; 1998 Apr; 77(7):1149-54. PubMed ID: 9569054
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Eight-hour infusion versus bolus injection of doxorubicin in the EAP regimen in patients with advanced gastric cancer: a prospective randomised trial.
    Popov I; Jelić S; Radulović S; Radosavljević D; Nikolić-Tomasević Z
    Ann Oncol; 2000 Mar; 11(3):343-8. PubMed ID: 10811503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
    Hayakawa M; Morise K; Chin K; Sugihara M; Morooka Y; Maeda H; Hattori T; Saito H
    Jpn J Clin Oncol; 1994 Oct; 24(5):282-8. PubMed ID: 7967107
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New developments in the treatment of gastric carcinoma.
    Wilke H; Preusser P; Fink U; Achterrath W; Mayer HJ; Stahl M; Lenaz L; Meyer J; Siewert JR; Gerlings H
    Cancer Treat Res; 1991; 55():363-73. PubMed ID: 1681867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Combination chemotherapy of methotrexate, etoposide, adriamycin and cisplatin (M-EAP) for advanced urothelial cancer].
    Hashimura T; Okumura K; Akao T; Nakagawa T
    Hinyokika Kiyo; 1991 Jul; 37(7):685-8. PubMed ID: 1927767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
    Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P
    Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG.
    Nitti D; Wils J; Dos Santos JG; Fountzilas G; Conte PF; Sava C; Tres A; Coombes RC; Crivellari D; Marchet A; Sanchez E; Bliss JM; Homewood J; Couvreur ML; Hall E; Baron B; Woods E; Emson M; Van Cutsem E; Lise M; ;
    Ann Oncol; 2006 Feb; 17(2):262-9. PubMed ID: 16293676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Etoposide, adriamycin, and cisplatinum (EAP) combination chemotherapy for advanced gastric cancer. A phase II trial by the "Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)".
    Räth U; Flechtner H; Selbach J; Harjung H; Manegold C; Kabelitz K; Trux FA; Edler L; Schlag P; Queisser W
    Onkologie; 1990 Jun; 13(3):194-7. PubMed ID: 2204005
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Advanced and recurrent gastric carcinoma: combination chemotherapy with etoposide (E), adriamycin (A), cisplatin (P) = EAP].
    Ohwada S; Miyamoto Y; Takeshita M; Fujii T; Uchida O; Tanahasi Y; Aoyagi H; Izuo M
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3487-9. PubMed ID: 2802641
    [No Abstract]   [Full Text] [Related]  

  • 54. Etoposide, doxorubicin and cisplatin (EAP) treatment in advanced gastric carcinoma: a multicentre study of the Italian Trials in Medical Oncology (I.T.M.O.) Group.
    Bajetta E; Di Bartolomeo M; de Braud F; Bozzetti F; Bochicchio AM; Comella P; Fagnani D; Farina G; Ferroni C; Franchi R
    Eur J Cancer; 1994; 30A(5):596-600. PubMed ID: 8080673
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemotherapy with etoposide, doxorubicin, cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma.
    Yuan JN; Chao Y; Lee WP; Li CP; Lee RC; Chang FY; Yen SH; Lee SD; Whang-Peng J
    Med Oncol; 2008; 25(2):201-6. PubMed ID: 18488159
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low toxic neoadjuvant cisplatin, 5-fluorouracil and folinic acid in locally advanced gastric cancer yields high R-0 resection rate.
    Menges M; Schmidt C; Lindemann W; Ridwelski K; Pueschel W; Jüngling B; Feifel G; Schilling M; Stallmach A; Zeitz M
    J Cancer Res Clin Oncol; 2003 Jul; 129(7):423-9. PubMed ID: 12836016
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase II trial of etoposide (V), adriamycin (A), and cisplatinum (P) in patients with metastatic gastric cancer.
    Katz A; Gansl RC; Simon SD; Gama-Rodrigues J; Waitzberg D; Bresciani CJ; Pinotti HW
    Am J Clin Oncol; 1991 Aug; 14(4):357-8. PubMed ID: 1862768
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advanced gastric cancer: a new combined surgical and oncological approach.
    Kremer B; Henne-Bruns D; Weh HJ; Effenberger T
    Hepatogastroenterology; 1989 Feb; 36(1):23-6. PubMed ID: 2744710
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phase II randomized trial of gallium nitrate plus fluorouracil versus methotrexate, vinblastine, doxorubicin, and cisplatin in patients with advanced transitional-cell carcinoma.
    McCaffrey JA; Hilton S; Mazumdar M; Sadan S; Heineman M; Hirsch J; Kelly WK; Scher HI; Bajorin DF
    J Clin Oncol; 1997 Jun; 15(6):2449-55. PubMed ID: 9196161
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.
    Hong RL; Sheen TS; Ko JY; Hsu MM; Wang CC; Ting LL
    Br J Cancer; 1999 Aug; 80(12):1962-7. PubMed ID: 10471046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.